A randomized Phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma
Open Access
- 15 January 1998
- Vol. 82 (2) , 292-300
- https://doi.org/10.1002/(sici)1097-0142(19980115)82:2<301::aid-cncr8>3.0.co;2-t
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.Journal of Clinical Oncology, 1994
- Trimetrexate: A Critical Appraisal of the Phase II Clinical Trial Experience: Evidence of Drug Discovery-Clinical Development DisjunctionCancer Investigation, 1994
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.Journal of Clinical Oncology, 1990
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Echinomycin: The first bifunctional intercalating agent in clinical trialsInvestigational New Drugs, 1985
- Trimetrexate: a new antifol entering clinical trialsInvestigational New Drugs, 1985
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952